PL386175A1 - Nowe szczepy bakteriofagów do leczenia zakażeń bakteryjnych, zwłaszcza szczepami bakterii lekoopornych rodzaju Enterococcus - Google Patents

Nowe szczepy bakteriofagów do leczenia zakażeń bakteryjnych, zwłaszcza szczepami bakterii lekoopornych rodzaju Enterococcus

Info

Publication number
PL386175A1
PL386175A1 PL386175A PL38617508A PL386175A1 PL 386175 A1 PL386175 A1 PL 386175A1 PL 386175 A PL386175 A PL 386175A PL 38617508 A PL38617508 A PL 38617508A PL 386175 A1 PL386175 A1 PL 386175A1
Authority
PL
Poland
Prior art keywords
strains
enterococcus
drug
treatment
bacterial infections
Prior art date
Application number
PL386175A
Other languages
English (en)
Other versions
PL215522B1 (pl
Inventor
Beata Weber-Dąbrowska
Andrzej Górski
Original Assignee
Instytut Immunologii i Terapii Doświadczalnej PAN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Immunologii i Terapii Doświadczalnej PAN filed Critical Instytut Immunologii i Terapii Doświadczalnej PAN
Priority to PL386175A priority Critical patent/PL215522B1/pl
Priority to EP09753232.9A priority patent/EP2344642B8/en
Priority to PCT/PL2009/050025 priority patent/WO2010036132A1/en
Priority to ES09753232T priority patent/ES2429125T3/es
Priority to US13/059,513 priority patent/US8440446B2/en
Publication of PL386175A1 publication Critical patent/PL386175A1/pl
Publication of PL215522B1 publication Critical patent/PL215522B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/00032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Ujawniono nowe szczepy bakteriofagowe i ich wykorzystanie do wytwarzania preparatów znajdujących zastosowanie w leczeniu zakażeń bakteryjnych, zwłaszcza szczepami bakterii lekoopornych rodzaju Enterococcus, szczególnie należącymi do gatunku Enterococcus faecalis.
PL386175A 2008-09-29 2008-09-29 Nowe szczepy bakteriofagów do leczenia zakazen bakteryjnych, zwlaszcza szczepami bakterii lekoopornych rodzaju Enterococcus PL215522B1 (pl)

Priority Applications (5)

Application Number Priority Date Filing Date Title
PL386175A PL215522B1 (pl) 2008-09-29 2008-09-29 Nowe szczepy bakteriofagów do leczenia zakazen bakteryjnych, zwlaszcza szczepami bakterii lekoopornych rodzaju Enterococcus
EP09753232.9A EP2344642B8 (en) 2008-09-29 2009-09-27 Novel bacteriophage strains for the treatment of bacterial infections, especially drug resistant strains of the genus enterococcus
PCT/PL2009/050025 WO2010036132A1 (en) 2008-09-29 2009-09-27 Novel bacteriophage strains for the treatment of bacterial infections, especially drug resistant strains of the genus enterococcus
ES09753232T ES2429125T3 (es) 2008-09-29 2009-09-27 Cepas novedosas de bacteriófagos para el tratamiento de infecciones bacterianas, especialmente cepas farmacorresistentes del género Enterococcus
US13/059,513 US8440446B2 (en) 2008-09-29 2009-09-27 Bacteriophage strains for the treatment of bacterial infections, especially drug resistant strains of the genus Enterococcus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL386175A PL215522B1 (pl) 2008-09-29 2008-09-29 Nowe szczepy bakteriofagów do leczenia zakazen bakteryjnych, zwlaszcza szczepami bakterii lekoopornych rodzaju Enterococcus

Publications (2)

Publication Number Publication Date
PL386175A1 true PL386175A1 (pl) 2010-04-12
PL215522B1 PL215522B1 (pl) 2013-12-31

Family

ID=41404327

Family Applications (1)

Application Number Title Priority Date Filing Date
PL386175A PL215522B1 (pl) 2008-09-29 2008-09-29 Nowe szczepy bakteriofagów do leczenia zakazen bakteryjnych, zwlaszcza szczepami bakterii lekoopornych rodzaju Enterococcus

Country Status (5)

Country Link
US (1) US8440446B2 (pl)
EP (1) EP2344642B8 (pl)
ES (1) ES2429125T3 (pl)
PL (1) PL215522B1 (pl)
WO (1) WO2010036132A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3115054B1 (en) 2009-02-06 2019-11-20 Technophage, Investigação E Desenvolvimento Em Biotecnologia, SA Antibacterial phage, phage peptides and methods of use thereof
WO2014160710A1 (en) * 2013-03-25 2014-10-02 Temple University - Of The Commonwealth System Of Higher Education Enterococcus faecalis bacteriophage and uses thereof
PL232951B1 (pl) 2013-06-03 2019-08-30 Inst Immunologii I Terapii Doswiadczalnej Im Ludwika Hirszfelda Polskiej Akademii Nauk Zastosowanie bakteriofaga T4
KR101587113B1 (ko) * 2014-10-29 2016-01-20 경북대학교 산학협력단 치주염 유발 장알균(Enterococcus faecalis)을 특이적으로 사멸시키는 신규한 박테리오파지
EP3233099A1 (en) * 2014-12-17 2017-10-25 Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. Phage therapy for targeting enterococci
CN110129279B (zh) * 2019-04-24 2022-02-18 昆明理工大学 一种粪肠球菌噬菌体及其分离、纯化、富集和应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB829266A (en) 1957-03-20 1960-03-02 Biogena A method of manufacturing bacteriophages in solid dry form
SU543260A1 (ru) 1975-07-25 1984-04-15 Всесоюзный Ордена Трудового Красного Знамени Научно-Исследовательский Противочумный Институт "Микроб" Способ получени холерных бактериофагов дл дифференциации вибрионов Эль-Тор на вирулентные и авирулентные
CS192212B1 (en) 1977-04-22 1979-08-31 Miloslav Mazacek Method of producing dry form bacteriophages
EP0290295B1 (en) 1987-05-07 1992-08-05 Microbial Developments Limited Antimicrobial preparations
WO1990003122A1 (en) 1988-09-26 1990-04-05 Microbial Developments Limited Antimicrobial preparations
GB8918983D0 (en) 1989-08-21 1989-10-04 Unilever Plc Composition for hygiene purposes
DE4005874A1 (de) 1990-02-24 1991-11-07 Boehringer Mannheim Gmbh Traegergebundene rekombinante proteine, verfahren zur herstellung und verwendung als immunogene und vakzine
GB2253859A (en) 1991-02-28 1992-09-23 Microbial Dev Ltd Use of bacteriophages to prevent microbial infestation
GB2255561B (en) 1991-04-20 1995-06-21 Agricultural & Food Res Lysins from bacteriophages
WO1995005454A1 (en) 1992-02-22 1995-02-23 Cambridge Bacteriophage Technologies Ltd. Engineered bacteriophages and vaccines containing them
GB9220027D0 (en) 1992-09-22 1992-11-04 Mini Agriculture & Fisheries Method and kits for detection of bacteria
WO1996007329A1 (en) 1994-09-09 1996-03-14 University Of Maryland Bacteriophage-encoded enzymes for the treatment and prevention of dental caries and periodontal diseases
GB9500851D0 (en) 1995-01-17 1995-03-08 Bionvent International Ab Method of selecting specific bacteriophages
DE19517940A1 (de) 1995-05-18 1996-11-21 Merck Patent Gmbh Nachweis von Listerien mittels rekombinanter Bakteriophagen
WO1998008944A1 (fr) 1996-08-26 1998-03-05 Bio Venture Bank Co., Ltd. Nouveau bacteriophage et procede de criblage associe, nouvelles matieres biobactericides preparees avec ledit bacteriophage et reactif utilise pour detecter celui-ci
RU2109055C1 (ru) 1996-11-27 1998-04-20 Дочернее предприятие "Биофаг" Научно-производственного объединения "Иммунопрепарат" Способ выделения бактериофагов
JP2002543816A (ja) 1999-05-13 2002-12-24 エクスポネンシャル バイオセラピーズ，アイエヌシー． バンコマイシン耐性腸球菌株に感染した患者を救済するために有用なバクテリオファージ株
AU5423400A (en) 1999-06-25 2001-01-31 Spring Diagnostics Ltd. Bacteriophage library useful for typing bacteria and system and method utilizingsame
ES2256028T3 (es) 1999-07-30 2006-07-16 Profos Ag Deteccion e identificacion de cepas bacterianas.

Also Published As

Publication number Publication date
WO2010036132A1 (en) 2010-04-01
PL215522B1 (pl) 2013-12-31
US20120122186A1 (en) 2012-05-17
EP2344642B8 (en) 2013-08-21
ES2429125T3 (es) 2013-11-13
EP2344642A1 (en) 2011-07-20
US8440446B2 (en) 2013-05-14
EP2344642B1 (en) 2013-07-03

Similar Documents

Publication Publication Date Title
ES2561253T3 (es) Bacterias probióticas que tienen actividad antioxidante y uso de las mismas
GB2482536B (en) Expression of antibody or a fragment thereof in lactobacillus
MX2016009898A (es) Tratamientos para acne resistente.
EA201270566A1 (ru) Противомикробные соединения и способы их получения и применения
ATE474585T1 (de) Probiotische enterokokken für eine verbesserte immunität
WO2013184755A3 (en) Seca inhibitors and methods of making and using thereof
MX349827B (es) Compuestos que contienen nitrogeno y su uso.
EA201270567A1 (ru) Противомикробные соединения и способы их получения и применения
MX2020005875A (es) Métodos y composiciones para prevenir la infección microbiana.
MX389212B (es) Métodos y composiciones de fermentación microbiana.
MX2018001075A (es) Agentes terapeuticos y profilacticos antibacterianos.
BR112012033212A2 (pt) uso de lactobacillo inibindo a produção de gás de bactéria coliforme isolada em infantes afetados por cólica
MX2015016444A (es) Metodos y composiciones de fermentacion bacteriana.
CL2008001367A1 (es) Compuestos derivados de heterociclos nitrogenados sustituidos; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una infeccion bacteriana.
EP4241844A3 (en) Compositions for topical treatment of microbial infections
TR201819164T4 (tr) Bi̇r bakteri̇yofaj suşu, spesi̇fi̇k bakteri̇yofaj suşlarinin elde edi̇lmesi̇ne yöneli̇k yöntem ve bunlarin kullanimi.
PL386175A1 (pl) Nowe szczepy bakteriofagów do leczenia zakażeń bakteryjnych, zwłaszcza szczepami bakterii lekoopornych rodzaju Enterococcus
CL2012002902A1 (es) Cepas de bacteriofagos especifica contra bacterias pertenecientes al genero vibrio para la profilaxis y terapia de vibrio anguillarum; y composicion antibacteriana que comprende dicha cepas.
WO2012019054A3 (en) Expression of antibody or a fragment thereof in lactobacillus
MX2014006686A (es) Derivaods novedosos de pirrol.
MX2017009450A (es) Composicion yodofora novedosa y metodos de uso.
CL2011002649A1 (es) Uso de un aerosol que comprende levofloxacina u ofloxacina para preparar un medicamento util para el tratamiento de una infeccion bacteriana pulmonar.
EA201500913A1 (ru) Противомикробные соединения и способы их получения и применения
AU2012335397A8 (en) Novel bacteriophages
CO2017007338A2 (es) Composición que comprende dos cepas de las especies microbianas lactobacillus rhamnosus y bifidobacterium longum capaces de incrementar la fertilidad masculina